Juan Fita, M.J.; Anido Herranz, U.; Mendez-Vidal, M.J.; Gironés-Sarrió, R.; Muñoz-Langa, J.; Sepúlveda-Sánchez, J.; Mellado, B.; Alvarez-Fernandez, C.; Heras López, L.; López-Guerrero, J.A.;
et al. Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study. Cancers 2023, 15, 5223.
https://doi.org/10.3390/cancers15215223
AMA Style
Juan Fita MJ, Anido Herranz U, Mendez-Vidal MJ, Gironés-Sarrió R, Muñoz-Langa J, Sepúlveda-Sánchez J, Mellado B, Alvarez-Fernandez C, Heras López L, López-Guerrero JA,
et al. Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study. Cancers. 2023; 15(21):5223.
https://doi.org/10.3390/cancers15215223
Chicago/Turabian Style
Juan Fita, María José, Urbano Anido Herranz, María José Mendez-Vidal, Regina Gironés-Sarrió, José Muñoz-Langa, Juan Sepúlveda-Sánchez, Begoña Mellado, Carlos Alvarez-Fernandez, Lucía Heras López, José Antonio López-Guerrero,
and et al. 2023. "Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study" Cancers 15, no. 21: 5223.
https://doi.org/10.3390/cancers15215223
APA Style
Juan Fita, M. J., Anido Herranz, U., Mendez-Vidal, M. J., Gironés-Sarrió, R., Muñoz-Langa, J., Sepúlveda-Sánchez, J., Mellado, B., Alvarez-Fernandez, C., Heras López, L., López-Guerrero, J. A., García-Casado, Z., Calatrava, A., & Ángel Climent, M.
(2023). Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study. Cancers, 15(21), 5223.
https://doi.org/10.3390/cancers15215223
